GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » International Isotopes Inc (OTCPK:INIS) » Definitions » Interest Expense

International Isotopes (International Isotopes) Interest Expense : $-0.33 Mil (TTM As of Dec. 2023)


View and export this data going back to 1997. Start your Free Trial

What is International Isotopes Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. International Isotopes's interest expense for the three months ended in Dec. 2023 was $ -0.08 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.33 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. International Isotopes's Operating Income for the three months ended in Dec. 2023 was $ -0.09 Mil. International Isotopes's Interest Expense for the three months ended in Dec. 2023 was $ -0.08 Mil. International Isotopes did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


International Isotopes Interest Expense Historical Data

The historical data trend for International Isotopes's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

International Isotopes Interest Expense Chart

International Isotopes Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.54 -0.78 -0.79 -0.61 -0.33

International Isotopes Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.15 -0.08 -0.08 -0.08 -0.08

International Isotopes Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.33 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


International Isotopes  (OTCPK:INIS) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

International Isotopes's Interest Expense for the three months ended in Dec. 2023 was $-0.08 Mil. Its Operating Income for the three months ended in Dec. 2023 was $-0.09 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was $3.98 Mil.

International Isotopes's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

International Isotopes did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


International Isotopes (International Isotopes) Business Description

Traded in Other Exchanges
N/A
Address
4137 Commerce Circle, Idaho Falls, ID, USA, 83401
International Isotopes Inc manufactures a full range of nuclear medicine calibration and reference standards, cobalt teletherapy sources, and other sealed sources. International Isotopes also distributes a varied selection of radioisotopes and radiochemicals for medical and clinical research, and pharmacy compounding. International Isotopes's business consists of four business segments: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, and Fluorine Products. Geographically, it generates the majority of its revenue from the United States.
Executives
W Matthew Cox officer: Chief Financial Officer C/O INTERNATIONAL ISOTOPES INC., 4137 COMMERCE CIRCLE, IDAHO FALLS ID 83401
Shahe Bagerdjian officer: President 4137 COMMERCE CIRCLE, IDAHO FALLS ID 83401
Christopher G Grosso director, 10 percent owner C/O KERSHNER GROSSO & CO, 480 BROADWAY, SARASOTA SPRINGS NY 12866
Robert Atcher director 4137 COMMERCE CIRCLE, IDAHO FALLS ID 83401
Laurie Mckenzie-carter officer: Chief Financial Officer 4137 COMMERCE CIRCLE, IDAHO FALLS ID 83401
Steve Laflin director, officer: Pres. & CEO 1258 E AIRPORT ROAD, BLACKFOOT ID 83221
William W Nicholson 10 percent owner 121 NORTH POST OAK LANE STE 2105, HOUSTON TX 77024
Ralph M Richard director, 10 percent owner 350 SHORE DRIVE, OAKDALE NY 11769
John M Mccormack 10 percent owner 4137 COMMERCE CIRCLE, IDAHO FALLS ID 83401
Walter D Ohearn other: Part of 13D group 1115 5TH AVENUE, NEW YORK NY 10128
Keane Marie C & Keane James Jtwros 10 percent owner